266 related articles for article (PubMed ID: 18305387)
1. Aspirin responsiveness in acute brain ischaemia: association with stroke severity and clinical outcome.
Schwammenthal Y; Tsabari R; Shenkman B; Schwartz R; Matetzky S; Lubetsky A; Orion D; Israeli-Korn S; Chapman J; Savion N; Varon D; Tanne D
Cerebrovasc Dis; 2008; 25(4):355-61. PubMed ID: 18305387
[TBL] [Abstract][Full Text] [Related]
2. Plasma triglycerides as predictors of platelet responsiveness to aspirin in patients after first ischemic stroke.
Karepov V; Tolpina G; Kuliczkowski W; Serebruany V
Cerebrovasc Dis; 2008; 26(3):272-6. PubMed ID: 18648200
[TBL] [Abstract][Full Text] [Related]
3. Variable platelet response to aspirin in patients with ischemic stroke.
Hohlfeld T; Weber AA; Junghans U; Schumacher M; Boucher M; Schrör K; Siebler M
Cerebrovasc Dis; 2007; 24(1):43-50. PubMed ID: 17519543
[TBL] [Abstract][Full Text] [Related]
4. Magnitude and time course of platelet inhibition with Aggrenox and Aspirin in patients after ischemic stroke: the AGgrenox versus Aspirin Therapy Evaluation (AGATE) trial.
Serebruany VL; Malinin AI; Sane DC; Jilma B; Takserman A; Atar D; Hennekens CH
Eur J Pharmacol; 2004 Sep; 499(3):315-24. PubMed ID: 15381054
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment with aspirin and etiology of first-ever ischemic stroke in young and middle-aged patients.
Telman G; Kouperberg E; Sprecher E; Yarnitsky D
J Neurol Sci; 2009 Jun; 281(1-2):2-5. PubMed ID: 19351569
[TBL] [Abstract][Full Text] [Related]
6. Partial inhibition of platelet thromboxane A2 synthesis by aspirin is associated with myonecrosis in patients with ST-segment elevation myocardial infarction.
Valles J; Santos MT; Fuset MP; Moscardo A; Ruano M; Perez F; Piñon M; Breña S; Aznar J
Am J Cardiol; 2007 Jan; 99(1):19-25. PubMed ID: 17196455
[TBL] [Abstract][Full Text] [Related]
7. Aspirin resistance in secondary stroke prevention.
Berrouschot J; Schwetlick B; von Twickel G; Fischer C; Uhlemann H; Siegemund T; Siegemund A; Roessler A
Acta Neurol Scand; 2006 Jan; 113(1):31-5. PubMed ID: 16367896
[TBL] [Abstract][Full Text] [Related]
8. Individual variability of response and non-response to acetyl salicylic acid after cardiac surgery.
Börgermann J; Kanashnik A; Sossdorf M; Gummert J; Lösche W
Platelets; 2010; 21(8):610-5. PubMed ID: 20807171
[TBL] [Abstract][Full Text] [Related]
9. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?
Hermann A; Dzialowski I; Koch R; Gahn G
J Neurol Sci; 2009 Sep; 284(1-2):155-7. PubMed ID: 19473668
[TBL] [Abstract][Full Text] [Related]
10. Enhanced ex vivo inhibition of platelet function following addition of dipyridamole to aspirin after transient ischaemic attack or ischaemic stroke: first results from the TRinity AntiPlatelet responsiveness (TrAP) study.
Tobin WO; Kinsella JA; Collins DR; Coughlan T; O'Neill D; Egan B; Tierney S; Feeley TM; Murphy RP; McCabe DJ
Br J Haematol; 2011 Mar; 152(5):640-7. PubMed ID: 21223254
[TBL] [Abstract][Full Text] [Related]
11. Lack of association between aspirin responsiveness and seven candidate gene haplotypes in patients with symptomatic vascular disease.
Kunicki TJ; Williams SA; Nugent DJ; Harrison P; Segal HC; Syed A; Rothwell PM
Thromb Haemost; 2009 Jan; 101(1):123-33. PubMed ID: 19132198
[TBL] [Abstract][Full Text] [Related]
12. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
Serebruany VL; Malinin AI; Pokov AN; Hanley DF
Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
[TBL] [Abstract][Full Text] [Related]
13. Towards a rationale of platelet aggregation monitoring in stroke prophylaxis?
von Lewinski F; Riggert J; Paulus W
J Stroke Cerebrovasc Dis; 2009; 18(2):111-5. PubMed ID: 19251186
[TBL] [Abstract][Full Text] [Related]
14. Blood pressure and antihypertensive therapy as predictors of early outcome in acute ischemic stroke.
Keezer MR; Yu AY; Zhu B; Wolfson C; Côté R
Cerebrovasc Dis; 2008; 25(3):202-8. PubMed ID: 18212508
[TBL] [Abstract][Full Text] [Related]
15. [Acetylsalicylic acid (ASA) resistance in patients with ischemic heart disease (IHD) as bioindicator of the treatment strategy].
Malý J; Pecka M; Gregor J; Dulícek P; Blazek M; Malý R; Pudil R; Bláha M
Cas Lek Cesk; 2005; 144 Suppl 3():23-9. PubMed ID: 16335259
[TBL] [Abstract][Full Text] [Related]
16. High incidence of severe ischaemic complications in patients with giant cell arteritis irrespective of platelet count and size, and platelet inhibition.
Berger CT; Wolbers M; Meyer P; Daikeler T; Hess C
Rheumatology (Oxford); 2009 Mar; 48(3):258-61. PubMed ID: 19129348
[TBL] [Abstract][Full Text] [Related]
17. Antiplatelet effect of clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions--limited inhibition of the P2Y12 receptor.
Lepäntalo A; Virtanen KS; Reséndiz JC; Mikkelsson J; Viiri LE; Karhunen PJ; Lassila R
Thromb Res; 2009 Jun; 124(2):193-8. PubMed ID: 19232433
[TBL] [Abstract][Full Text] [Related]
18. Can aspirin resistance be clinically predicted in stroke patients?
Seok JI; Joo IS; Yoon JH; Choi YJ; Lee PH; Huh K; Bang OY
Clin Neurol Neurosurg; 2008 Feb; 110(2):110-6. PubMed ID: 17964711
[TBL] [Abstract][Full Text] [Related]
19. Optical platelet aggregometry does not appear useful as a means of assessing the risk of recurrent vascular events in aspirin-treated patients.
Sztriha LK; Sas K; Seres E; Boda K; Lenti L; Csifcsak G; Kovacs N; Vecsei L
Acta Neurol Scand; 2008 Apr; 117(4):250-4. PubMed ID: 17961197
[TBL] [Abstract][Full Text] [Related]
20. Triflusal and aspirin have different effects on inflammatory biomarkers measured in patients with acute ischemic stroke.
Alvarez-Sabín J; Penalba A; Quintana M; Krupinski J; García-Bonilla L; Montaner J
Cerebrovasc Dis; 2009; 28(4):371-7. PubMed ID: 19641312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
